The third round of the Medicare Drug Price Negotiation Program is moving forward with full manufacturer participation. The program, created under the Inflation Reduction Act, allows CMS to directly ...

President Donald Trump’s approach to lowering drug prices has leaned heavily on executive orders and voluntary deals with drugmakers, rather than legislation. (Andrew Harnik / Getty Images) As ...

As the Trump administration begins to make its mark on the Medicare drug price negotiation program and pursue its own policies on prescription drugs, litigation over program continues. In the two ...

The Centers for Medicare and Medicaid Services (CMS) and pharmaceutical drug manufacturers are gearing up for the second round of negotiations as part of the Medicare Drug Price Negotiation Program ...

A federal appellate court has handed down the first appellate-level decision addressing the merits of drug manufacturers’ challenges to the Inflation Reduction Act of 2022's (IRA) Medicare Drug ...

ALEXANDRIA, Va.--(BUSINESS WIRE)--Today, the National Community Pharmacists Association released a first-of-its-kind analysis, Unpacking the Financial Impacts of Medicare Drug Price Negotiation, ...

The National Community Pharmacists Association has told CMS that more than 90% of independent pharmacies may choose to stop stocking drugs included in the Medicare Drug Price Negotiation Program due ...

The Trump administration signaled Medicare drug price negotiations under the Inflation Reduction Act (IRA) signed in 2022 by former President Joe Biden may undergo a reexamination to add greater ...

Many independent pharmacists may decide or have already decided not to carry drugs in the Medicare Drug Price Negotiation Program due to financial challenges, the National Community Pharmacists ...

NEW YORK (AP) — Drugs that treat Type 2 diabetes, HIV and arthritis are among 15 new medications chosen for a Medicare drug price negotiation program that allows the federal government to haggle ...

This article is the latest in the Health Affairs Forefront featured topic, “Health Policy at a Crossroads,” produced with the support of the Commonwealth Fund and the Robert Wood Johnson Foundation.